Addison Collins, PA
Medical · Bozeman, MTNPI 1548722242
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 39.6% of the total. Among medical clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$367
- E.r. Squibb & Sons, L.L.C.$318
- Novartis$221
- Sanofi$200
- Merz North America, Inc.$157
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,87798%
- Education$722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 99 | $1,564 |
| Amgen | 21 | $367 |
| E.r. Squibb & Sons, L.L.C. | 17 | $318 |
| Novartis | 11 | $221 |
| Sanofi | 9 | $200 |
| Merz North America, Inc. | 2 | $157 |
| Lilly USA, LLC | 8 | $146 |
| LEO Pharma Inc. | 4 | $138 |
| Sun Pharmaceutical Industries Inc. | 4 | $138 |
| Kyowa Kirin, Inc. | 8 | $115 |
| Johnson & Johnson | 7 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Galderma Laboratories, L.p. | 2 | $79 |
| Pfizer | 5 | $75 |
| UCB, Inc. | 4 | $62 |
| Boehringer Ingelheim | 3 | $50 |
| Genentech USA, Inc. | 8 | $45 |
| Incyte Corporation | 3 | $43 |
| Blueprint Medicines Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$131
How this compares
$3,949 in reported general payments places this provider in the 90th percentile of 134 medical providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $530 |
| Ketoconazole | 15 | $266 |
| Triamcinolone Acetonide | 33 | $261 |
Paid to pharmacies, not to this prescriber.
Other medical in Bozeman
- Melissa PewBozeman$3K
- Elizabeth AnsleyBozeman$2K
- Ashley AndertonBozeman$2K
- Catherine WalgrenBozeman$2K
- Alison HallBozeman$471
- Sarah AdsitBozeman$328
- Susan WhittinghillBozeman$262
- Cynthia CarterBozeman$234
- Mackenzie GeorgeKalispell$9K
- David BrostGreat Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.